Uterine volume (cm³) · women with uterine fibroids
1 finding from 1 review
Operating time · women with uterine fibroids
3 findings from 1 review
no estimate extracted
6 studies · 443 participants
Very low
no estimate extracted
1 study · 39 participants
Low
no estimate extracted
6 studies · 617 participants
Low
Intraoperative blood loss (mL) · women with uterine fibroids
3 findings from 1 review
Blood transfusion · women with uterine fibroids
GnRHa treatment showed no clear difference in blood transfusions compared with no pretreatment or placebo before myomectomy (operative and… (low certainty).
3 findings from 1 review
Overall postoperative morbidity · women with uterine fibroids
GnRHa treatment showed no clear difference in postoperative morbidity compared with no pretreatment or placebo before myomectomy (operative and… (low certainty).
3 findings from 1 review
Fibroid volume (cm³) · women with uterine fibroids
1 finding from 1 review
Haemoglobin (g/dL) · women with uterine fibroids
1 finding from 1 review
Preoperative bleeding · women with uterine fibroids
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · women with uterine fibroids
GnRHa treatment probably leads to higher adverse events compared with placebo or no pretreatment (preoperative outcomes) (moderate certainty).
1 finding from 1 review
Uterine volume (cm³) · women with uterine fibroids
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Fibroid volume (cm³) · women with uterine fibroids
1 finding from 1 review
Haemoglobin (g/dL) · women with uterine fibroids
1 finding from 1 review
Preoperative bleeding: (PBAC < 75) ulipristal acetate 5 mg · women with uterine fibroids
GnRHa treatment showed no clear difference in preoperative bleeding: Reduction in bleeding to PBAC < 75 ulipristal… compared with other medical therapies before any surgery (moderate certainty).
1 finding from 1 review
Preoperative bleeding: Reduction in bleeding to PBAC < 75 ulipristal acetate 10 mg · women with uterine fibroids
GnRHa treatment showed no clear difference in preoperative bleeding: Reduction in bleeding to PBAC < 75 ulipristal… compared with other medical therapies before any surgery (moderate certainty).
1 finding from 1 review
Adverse events (hot flushes) · women with uterine fibroids
GnRHa treatment may leads to higher adverse events (hot flushes) compared with other medical therapies before any surgery (low certainty).
1 finding from 1 review
GnRHas vs gestrinone Percentage change values ‐ 12 months · Women with endometriosis, treated with GnRHas with effect on bone mineral density
2 findings from 1 review
GnRHas vs GnRHas in conjunction with calcium‐regulating agents Anterior‐posterior spine ‐ 12 months · Women with endometriosis, treated with GnRHas with effect on bone mineral density
1 finding from 1 review
GnRHas vs GnRHas in conjunction with calcium‐regulating agents Lateral spine ‐ 12 months · Women with endometriosis, treated with GnRHas with effect on bone mineral density
1 finding from 1 review
Number of days of gonadotrophin treatment ‐ half dose · women undergoing pituitary suppression in assisted reproduction
1 finding from 1 review
Number of days of gonadotrophin treatment ‐ full dose · women undergoing pituitary suppression in assisted reproduction
1 finding from 1 review